The DOI matches its Crossref record; 170 of the 170 references it cites were found in a registry or an index.
Complement, a target for therapy in inflammatory and degenerative diseases
Open accessAbstract
The complement system is a key innate immune defence against infection and an important driver of inflammation; however, these very properties can also cause harm. Inappropriate or uncontrolled activation of complement can cause local and/or systemic inflammation, tissue damage and disease. Complement provides numerous options for drug development as it is a proteolytic cascade that involves nine specific proteases, unique multimolecular activation and lytic complexes, an arsenal of natural inhibitors, and numerous receptors that bind to activation fragments. Drug design is facilitated by the increasingly detailed structural understanding of the molecules involved in the complement system. Only two anti-complement drugs are currently on the market, but many more are being developed for diseases that include infectious, inflammatory, degenerative, traumatic and neoplastic disorders. In this Review, we describe the history, current landscape and future directions for anti-complement therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654 · cited 1×
“Many other roles of complement continue to emerge, including directing haematopoietic stem cells to marrow niches, regulating triglyceride uptake and storage in adipose tissue and the regeneration of damaged tissue after injury and during wound healing 16 .”
BackgroundBhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Age-related macular degeneration
Jager, R. D., Mieler, W. F., & Miller, J. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0801537 · Cited by 1,379
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Weisman, H. F., Bartow, T., Leppo, M. K., Marsh, H. C., Carson, G. R., Concino, M. F., Boyle, M. P., Roux, K. H., Weisfeldt, M. L., & Fearon, D. T. (1990) · Science · doi:10.1126/science.2371562 · Cited by 977
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Complement C3 variant and the risk of age-related macular degeneration
Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072618 · Cited by 829
Rother, R. P., Rollins, S. A., Mojcik, C. F., Brodsky, R. A., & Bell, L. (2007) · Nature Biotechnology · doi:10.1038/nbt1344 · Cited by 778 · cited 2×
“The C5-specific mAb eculizumab binds to C5 remote from the cleavage site, at a site in the α-chain that prevents C5 from binding to C5 convertase 24, 25, 149 .”
BackgroundThe role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
Brodsky, R. A., Young, N. S., Antonioli, E., Risitano, A. M., Schrezenmeier, H., Schubert, J., Gaya, A., Coyle, L., de Castro, C., Fu, C.-L., et al. (2008) · Blood · doi:10.1182/blood-2007-06-094136 · Cited by 652
Paroxysmal nocturnal hemoglobinuria
Brodsky, R. A. (2014) · Blood · doi:10.1182/blood-2014-02-522128 · Cited by 648
Hillmen, P., Hall, C., Marsh, J. C. W., Elebute, M., Bombara, M. P., Petro, B. E., Cullen, M. J., Richards, S. J., Rollins, S. A., Mojcik, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031688 · Cited by 635
Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
Stegall, M. D., Diwan, T., Raghavaiah, S., Cornell, L. D., Burns, J., Dean, P. G., Cosio, F. G., Gandhi, M. J., Kremers, W., & Gloor, J. M. (2011) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2011.03757.x · Cited by 577
Identification of a central role for complement in osteoarthritis
Wang, Q., Rozelle, A. L., Lepus, C. M., Scanzello, C. R., Song, J. J., Larsen, D. M., Crish, J. F., Bebek, G., Ritter, S. Y., Lindstrom, T. M., et al. (2011) · Nature Medicine · doi:10.1038/nm.2543 · Cited by 575
Till, G. O., Johnson, K. J., Kunkel, R., & Ward, P. A. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110548 · Cited by 549
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies
on behalf of the French Study Group for aHUS/C3G, Zuber, J., Fakhouri, F., Roumenina, L. T., Loirat, C., & Frémeaux-Bacchi, V. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.214 · Cited by 496
Genetic Variants in C5 and Poor Response to Eculizumab
Nishimura, J.-I., Yamamoto, M., Hayashi, S., Ohyashiki, K., Ando, K., Brodsky, A. L., Noji, H., Kitamura, K., Eto, T., Takahashi, T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311084 · Cited by 417
Pittock, S. J., Lennon, V. A., McKeon, A., Mandrekar, J., Weinshenker, B. G., Lucchinetti, C. F., O'Toole, O., & Wingerchuk, D. M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70076-0 · Cited by 395
Hillmen, P., Muus, P., Röth, A., Elebute, M. O., Risitano, A. M., Schrezenmeier, H., Szer, J., Browne, P., Maciejewski, J. P., Schubert, J., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12347 · Cited by 394
Regulation of Humoral Immunity by Complement
Carroll, M. C., & Isenman, D. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.002 · Cited by 387
STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Noris, M., Mescia, F., & Remuzzi, G. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.195 · Cited by 383
Inhibition of complement activity by humanized anti-C5 antibody and single-chain Fv
Thomas, T. C., Rollins, S. A., Rother, R. P., Giannoni, M. A., Hartman, S. L., Elliott, E. A., Nye, S. H., Matis, L. A., Squinto, S. P., & Evans, M. J. (1996) · Molecular Immunology · doi:10.1016/s0161-5890(96)00078-8 · Cited by 363
Wang, Y., Rollins, S. A., Madri, J. A., & Matis, L. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8955 · Cited by 360
Moore, I., Strain, L., Pappworth, I., Kavanagh, D., Barlow, P. N., Herbert, A. P., Schmidt, C. Q., Staniforth, S. J., Holmes, L. V., Ward, R., et al. (2010) · Blood · doi:10.1182/blood-2009-05-221549 · Cited by 357
ROLE OF COMPLEMENT IN INDUCTION OF ANTIBODY PRODUCTION IN VIVO
Pepys, M. B. (1974) · The Journal of Experimental Medicine · doi:10.1084/jem.140.1.126 · Cited by 356
Membrane complement regulatory proteins
Kim, D. D., & Song, W.-C. (2006) · Clinical Immunology · doi:10.1016/j.clim.2005.10.014 · Cited by 353
Manuelian, T., Hellwage, J., Meri, S., Caprioli, J., Noris, M., Heinen, S., Jozsi, M., Neumann, H. P. H., Remuzzi, G., & Zipfel, P. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16651 · Cited by 350
Atypical Hemolytic Uremic Syndrome
Kavanagh, D., Goodship, T. H., & Richards, A. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.003 · Cited by 348
Dynamics of complement activation in aHUS and how to monitor eculizumab therapy
Noris, M., Galbusera, M., Gastoldi, S., Macor, P., Banterla, F., Bresin, E., Tripodo, C., Bettoni, S., Donadelli, R., Valoti, E., et al. (2014) · Blood · doi:10.1182/blood-2014-02-558296 · Cited by 341
Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Di Cioccio, V., Cesta, M. C., Galliera, E., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402090101 · Cited by 333
Wu, J., Wu, Y.-Q., Ricklin, D., Janssen, B. J. C., Lambris, J. D., & Gros, P. (2009) · Nature Immunology · doi:10.1038/ni.1755 · Cited by 327
Complement deficiencies and systemic lupus erythematosus
Truedsson, L., Bengtsson, A. A., & Sturfelt, G. (2007) · Autoimmunity · doi:10.1080/08916930701510673 · Cited by 315
(1984) · Food and Chemical Toxicology · doi:10.1016/0278-6915(84)90178-9 · Cited by 309
Yehoshua, Z., Alexandre de Amorim Garcia Filho, C., Nunes, R. P., Gregori, G., Penha, F. M., Moshfeghi, A. A., Zhang, K., Sadda, S., Feuer, W., & Rosenfeld, P. J. (2014) · Ophthalmology · doi:10.1016/j.ophtha.2013.09.044 · Cited by 299
Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
Forneris, F., Ricklin, D., Wu, J., Tzekou, A., Wallace, R. S., Lambris, J. D., & Gros, P. (2010) · Science · doi:10.1126/science.1195821 · Cited by 288
Rosen, F. S., Alper, C. A., Pensky, J., Klemperer, M. R., & Donaldson, V. H. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106708 · Cited by 267
Sahu, A., Kay, B. K., & Lambris, J. D. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.2.884 · Cited by 264
Kang, J. S., DeLuca, P. P., & Lee, K. C. (2009) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210902907847 · Cited by 252
Protein–protein interaction inhibitors get into the groove
Mullard, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3680 · Cited by 243
Complement deficiency states and associated infections
Skattum, L., van Deuren, M., van der Poll, T., & Truedsson, L. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.05.001 · Cited by 240
Heurich, M., Martínez-Barricarte, R., Francis, N. J., Roberts, D. L., Rodríguez de Córdoba, S., Morgan, B. P., & Harris, C. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019338108 · Cited by 231
Self-citationImmunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis
Gordon, P. A., Winer, J. B., Hoogendijk, J. E., & Choy, E. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003643.pub4 · Cited by 230
Howard, J. F., Barohn, R. J., Cutter, G. R., Freimer, M., Juel, V. C., Mozaffar, T., Mellion, M. L., Benatar, M. G., Farrugia, M. E., Wang, J. J., et al. (2013) · Muscle & Nerve · doi:10.1002/mus.23839 · Cited by 225
The genetics and immunobiology of IgA nephropathy
Kiryluk, K., & Novak, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74475 · Cited by 224
The Amplification Loop of the Complement Pathways
Lachmann, P. J. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(08)04004-2 · Cited by 220
Complement Inhibitor of C5 Activation from the Soft Tick Ornithodoros moubata
Nunn, M. A., Sharma, A., Paesen, G. C., Adamson, S., Lissina, O., Willis, A. C., & Nuttall, P. A. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.2084 · Cited by 212
Compstatin: a C3‐targeted complement inhibitor reaching its prime for bedside intervention
Mastellos, D. C., Yancopoulou, D., Kokkinos, P., Huber‐Lang, M., Hajishengallis, G., Biglarnia, A. R., Lupu, F., Nilsson, B., Risitano, A. M., Ricklin, D., et al. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12419 · Cited by 206
The role of complement in the early immune response to transplantation
Sacks, S. H., & Zhou, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3225 · Cited by 197
Rheumatoid arthritis and the complement system
Okroj, M., Heinegård, D., Holmdahl, R., & Blom, A. M. (2007) · Annals of Medicine · doi:10.1080/07853890701477546 · Cited by 184
Atkinson, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25208 · Cited by 181
Holers, V., Kinoshita, T., & Molina, H. (1992) · Immunology today (Amsterdam. Regular ed.) · doi:10.1016/0167-5699(92)90160-9 · Cited by 169
Grumach, A. S., & Kirschfink, M. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.030 · Cited by 169
The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia
Håvik, B., Le Hellard, S., Rietschel, M., Lybæk, H., Djurovic, S., Mattheisen, M., Mühleisen, T. W., Degenhardt, F., Priebe, L., Maier, W., et al. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.030 · Cited by 168
Wu, M. C. L., Brennan, F. H., Lynch, J. P. L., Mantovani, S., Phipps, S., Wetsel, R. A., Ruitenberg, M. J., Taylor, S. M., & Woodruff, T. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218815110 · Cited by 165
Vergunst, C. E., Gerlag, D. M., Dinant, H., Schulz, L., Vinkenoog, M., Smeets, T. J. M., Sanders, M. E., Reedquist, K. A., & Tak, P. P. (2007) · Rheumatology · doi:10.1093/rheumatology/kem222 · Cited by 163
The complotype: dictating risk for inflammation and infection
Harris, C. L., Heurich, M., Cordoba, S. R. D., & Morgan, B. P. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.06.001 · Cited by 163
Self-citationCompstatin: A Complement Inhibitor on its Way to Clinical Application
Ricklin, D., & Lambris, J. D. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78952-1_20 · Cited by 162
Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration
Woodruff, T. M., Crane, J. W., Proctor, L. M., Buller, K. M., Shek, A., Vos, K. J. D., Pollitt, S., Williams, H. M., Shiels, I. A., Monk, P. N., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5814com · Cited by 154
Lonze, B. E., Zachary, A. A., MAGRO, C. M. J., Desai, N. M., Orandi, B. J., Dagher, N. N., Singer, A. L., Carter‐Monroe, N., Nazarian, S., Segev, D. L., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12540 · Cited by 153
Riedl, M., Fakhouri, F., Quintrec, M. L., Noone, D. G., Jungraithmayr, T., Frémeaux‐Bacchi, V., & Licht, C. P. B. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1376153 · Cited by 145
Fluiter, K., Opperhuizen, A., Morgan, B. P., Baas, F., & Ramaglia, V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302793 · Cited by 145
Self-citationThe complement system in ischemia–reperfusion injuries
Gorsuch, W. B., Chrysanthou, E., Schwaeble, W., & Stahl, G. L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.024 · Cited by 144
Orsini, F., Villa, P., Parrella, S., Zangari, R., Zanier, E. R., Gesuete, R., Stravalaci, M., Fumagalli, S., Ottria, R., Reina, J. J., et al. (2012) · Circulation · doi:10.1161/circulationaha.112.103051 · Cited by 140
Qu, H., Ricklin, D., Bai, H., Chen, H., Reis, E. S., Maciejewski, M., Τζέκου, Α., DeAngelis, R. A., Resuello, R. R. G., Lupu, F., et al. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.06.003 · Cited by 139
Peanuts can contribute to anaphylactic shock by activating complement
Khodoun, M. V., Strait, R. T., Orekov, T., Hogan, S. P., Karasuyama, H., Herbert, D. R., Köhl, J., & Finkelman, F. D. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.11.004 · Cited by 136
Structure of and influence of a tick complement inhibitor on human complement component 5
Fredslund, F., Laursen, N. S., Roversi, P., Jenner, L. B., Oliveira, C. L. P., Pedersen, J. S., Nunn, M. A., Lea, S. M., DiScipio, R. G., Sottrup‐Jensen, L., et al. (2008) · Nature Immunology · doi:10.1038/ni.1625 · Cited by 134
The complement system in human cardiometabolic disease
Hertle, E., Stehouwer, C. D. A., & van Greevenbroek, M. M. J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.031 · Cited by 133
Rational Engineering of a Minimized Immune Inhibitor with Unique Triple-Targeting Properties
Schmidt, C. Q., Bai, H., Lin, Z., Risitano, A. M., Barlow, P. N., Ricklin, D., & Lambris, J. D. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203548 · Cited by 132
Eculizumab treatment for rescue of renal function in IgA nephropathy
Rosenblad, T., Rebetz, J., Johansson, M., Békássy, Z. D., Sartz, L., & Karpman, D. (2014) · Pediatric Nephrology · doi:10.1007/s00467-014-2863-y · Cited by 127
Metabolism of complement factor D in renal failure
Pascual, M. A., Steiger, G., Estreicher, J., Macon, K. J., Volanakis, J. E., & Schifferli, J. A. (1988) · Kidney International · doi:10.1038/ki.1988.214 · Cited by 126
Risitano, A. M., Notaro, R., Pascariello, C., Sica, M., Vecchio, L. D., Horvath, C. J., Fridkis‐Hareli, M., Selleri, C., Lindorfer, M. A., Taylor, R. P., et al. (2012) · Blood · doi:10.1182/blood-2011-12-398792 · Cited by 125
Fridkis‐Hareli, M., Storek, M., Mazsaroff, I., Risitano, A. M., Lundberg, A. S., Horvath, C. J., & Holers, V. M. (2011) · Blood · doi:10.1182/blood-2011-06-359646 · Cited by 121
The role of complement in trauma and fracture healing
Huber-Lang, M. S., Kovtun, A., & Ignatius, A. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.05.006 · Cited by 120
Diabetic angiopathy, the complement system and the tumor necrosis factor superfamily
Flyvbjerg, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.266 · Cited by 115
Toward a structure-based comprehension of the lectin pathway of complement
Kjær, T. R., Thiel, S., & Andersen, G. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.220 · Cited by 115
Complement dysregulation and disease: From genes and proteins to diagnostics and drugs
de Córdoba, S. R., Tortajada, A., Harris, C. L., & Morgan, B. P. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.021 · Cited by 115
Self-citationComplement in multiple sclerosis: its role in disease and potential as a biomarker
Ingram, G., Hakobyan, S. A., Robertson, N. P., & Morgan, B. P. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03830.x · Cited by 114
Self-citationComplement Factors C3a, C4a, and C5a in Chronic Obstructive Pulmonary Disease and Asthma
Marc, M. M., Korošec, P., Košnik, M., Kern, I., Fležar, M., Šuškovič, S., & Šorli, J. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2003-0394oc · Cited by 114
Fc-Based Cytokines: Prospects for Engineering Superior Therapeutics
Jazayeri, J. A., & Carroll, G. J. (2008) · BioDrugs · doi:10.2165/00063030-200822010-00002 · Cited by 103
Immunomodulation in psoriatic arthritis: Focus on cellular and molecular pathways
Chimenti, M. S., Ballanti, E., Perricone, C., Cipriani, P., Giacomelli, R., & Perricone, R. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.10.002 · Cited by 102
Pharmacokinetics and concentration–effect relationship of adalimumab in rheumatoid arthritis
Ternant, D., Ducourau, É., Fuzibet, P., Desvignes, C., Watier, H., Lequerré, T., Loët, X. L., Vittecoq, O., Goupille, P., Mulleman, D., et al. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12509 · Cited by 100
C1-inhibitor in patients with severe sepsis and septic shock: Beneficial effect on renal dysfunction
Caliezi, C., Zeerleder, S. S., Redondo, M., Regli, B., Rothen, H.-U., Zenklusen, R. M. Z., Rieben, R., Devay, J., Hack, C. E., Lämmle, B., et al. (2002) · Critical Care Medicine · doi:10.1097/00003246-200208000-00008 · Cited by 99
A complex role for complement in allergic asthma
Zhang, X., & Köhl, J. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.09.84 · Cited by 99
Morgan, B. P., Chamberlain-Banoub, J. L., Neal, J., Song, W., Mizuno, M., & Harris, C. L. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03205.x · Cited by 99
Self-citationDetection of complement activation using monoclonal antibodies against C3d
Thurman, J. M., Kulik, L. N., Orth, H. N., Wong, M., Renner, B., Sargsyan, S. A., Mitchell, L. M., Hourcade, D. E., Hannan, J. P., Kovacs, J. M., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65861 · Cited by 95
Specific Inhibition of the Classical Complement Pathway by C1q-Binding Peptides
Roos, A., Nauta, A. J., Broers, D., Faber‐Krol, M. C., Trouw, L. A., Drijfhout, J. W., & Daha, M. R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.12.7052 · Cited by 95
Complement activation and inhibition in experimental models of arthritis
Linton, S. M., & Morgan, B. P. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)00113-3 · Cited by 94
Self-citationHoehlig, K., Maasch, C., Shushakova, N., Buchner, K., Huber-Lang, M. S., Purschke, W. G., Vater, A., & Klußmann, S. (2013) · Molecular Therapy · doi:10.1038/mt.2013.178 · Cited by 93
Toward a structure-based comprehension of the lectin pathway of complement
Kjær, T. R., Thiel, S., & Andersen, G. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.05.007 · Cited by 92
“Chemokine receptors as therapeutic targets: Why aren’t there more drugs?”
Solari, R. C. E., Pease, J. E., & Begg, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.06.060 · Cited by 91
Frei, Y., Lambris, J. D., & Stockinger, B. (1987) · Molecular and Cellular Probes · doi:10.1016/0890-8508(87)90022-3 · Cited by 90
Sofat, R., Casas, J. P., Webster, A. R., Bird, A. C., Mann, S. S., Yates, J. R. W., Moore, A. T., Sepp, T., Cipriani, V., Bunce, C., et al. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr204 · Cited by 89
Comparative Functional Evolution of Human and Mouse CR1 and CR2,
Jacobson, A. C., & Weis, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.2953 · Cited by 87
Väkevä, A., Jauhiainen, M., Ehnholm, C., Lehto, T., & Meri, S. (1994) · PubMed Central · Cited by 85
Role of Complement in Multiorgan Failure
Rittirsch, D., Redl, H. R., & Huber-Lang, M. S. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/962927 · Cited by 85
Complement deficiencies in humans and animals: Links to autoimmunity
Lewis, M., & Botto, M. (2006) · Autoimmunity · doi:10.1080/08916930600739233 · Cited by 85
Hepburn, N. J., Williams, A. S., Nunn, M. A., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609858200 · Cited by 84
Héja, D., Harmat, V., Fodor, K., Wilmanns, M., Dobó, J., Kékesi, K. A., Závodszky, P., Gál, P., & Pál, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.354332 · Cited by 84
Coppens, M., Eikelboom, J. W., Gustafsson, D., Weitz, J. I., & Hirsh, J. (2012) · Circulation Research · doi:10.1161/circresaha.112.264903 · Cited by 83
Antibody-directed enzyme prodrug therapy (ADEPT) for cancer
Bagshawe, K. D., Sharma, S. K., & Beǵent, R. H. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.11.1777 · Cited by 81
Heydenreich, N., Nolte, M. W., Göb, E., Langhauser, F., Hofmeister, M., Kraft, P., Albert-Weißenberger, C., Brede, M., Várallyay, C. G., Göbel, K., et al. (2012) · Stroke · doi:10.1161/strokeaha.112.660340 · Cited by 80
Inhibiting Alternative Pathway Complement Activation by Targeting the Factor D Exosite
Katschke, K. J., Wu, P., Ganesan, R., Kelley, R. F., Mathieu, M. A., Hass, P. E., Murray, J. M., Kirchhofer, D., Wiesmann, C., & Campagne, M. V. L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.345082 · Cited by 78
Paroxysmal nocturnal hemoglobinuria and other complement-mediated hematological disorders
Risitano, A. M. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.014 · Cited by 78
Systemic complement profiling in multiple sclerosis as a biomarker of disease state
Ingram, G., Hakobyan, S. A., Hirst, C. L., Harris, C. L., Loveless, S., Mitchell, J., Pickersgill, T., Robertson, N., & Morgan, B. P. (2012) · Multiple Sclerosis Journal · doi:10.1177/1352458512438238 · Cited by 77
Self-citationLazar, H. L., Bokesch, P. M., van Lenta, F., Fitzgerald, C. A., Emmett, C., Marsh, H. C., Ryan, U. S., & OBE and the TP10 Cardiac Surgery Study Group (2004) · Circulation · doi:10.1161/01.cir.0000138315.99788.eb · Cited by 76
Complement modulation of T cell immune responses during homeostasis and disease
Clarke, E. V., & Tenner, A. J. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0214-109r · Cited by 76
Properdin in complement activation and tissue injury
Lesher, A. M., Nilsson, B., & Song, W. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.06.002 · Cited by 75
Willison, H. J., Halstead, S. K., Beveridge, E., Zitman, F. M. P., Greenshields, K. N., Morgan, B. P., & Plomp, J. J. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.05.028 · Cited by 74
Self-citationDense Deposit Disease and C3 Glomerulopathy
Barbour, T., Pickering, M. C., & Cook, H. T. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2013.08.002 · Cited by 72
Kaplan, M. J. (2002) · PubMed · Cited by 72
Targeting complement component 5a promotes vascular integrity and limits airway remodeling
Khan, M. A., Maasch, C., Vater, A., Klußmann, S., Morser, J., Leung, L. L. K., Atkinson, C., Tomlinson, S., Heeger, P. S., & Nicolls, M. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217991110 · Cited by 69
Phuan, P., Zhang, H., Asavapanumas, N., Leviten, M. W., Rosenthal, A., Tradtrantip, L., & Verkman, A. S. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1128-3 · Cited by 68
Ricklin, D., Τζέκου, Α., Garcia, B. L., Hammel, M., McWhorter, W. J., Sfyroera, G., Wu, Y., Holers, V. M., Herbert, A. P., Barlow, P. N., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901443 · Cited by 67
Hebecker, M., Alba‐Domínguez, M., Roumenina, L. T., Reuter, S., Hyvärinen, S., Dragon‐Durey, M., Jokiranta, T. S., Sánchez‐Corral, P., & Józsi, M. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300269 · Cited by 67
Generation of a Recombinant, Membrane-targeted Form of the Complement Regulator CD59
Fraser, D. A., Harris, C. L., Williams, A. S., Mizuno, M., Gallagher, S., Smith, R. A., & Morgan, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302598200 · Cited by 66
Self-citationLi, Y., Zhou, K., Zhang, Z., Sun, L., Yang, J., Zhang, M., Ji, B., Tang, K., Wei, Z., He, G., et al. (2012) · Molecular BioSystems · doi:10.1039/c2mb25158b · Cited by 65
Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters
Reis, E. S., DeAngelis, R. A., Chen, H., Resuello, R. R. G., Ricklin, D., & Lambris, J. D. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.026 · Cited by 65
Chi, Z., Yoshida, T., Lambris, J. D., & Iwata, T. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5635-4_9 · Cited by 64
Lewis, R. D., Jackson, C. L., Morgan, B. P., & Hughes, T. R. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.035 · Cited by 63
Self-citationUpdate on current and future novel therapies for dry age-related macular degeneration
Leung, E. H., & Landa, G. (2013) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2013.829645 · Cited by 61
Katschke, K. J., Stawicki, S. S., Yin, J., Steffek, M., Xi, H., Sturgeon, L., Hass, P. E., Loyet, K. M., DeForge, L. E., Wu, Y., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809106200 · Cited by 61
Huber-Lang, M. S., Barratt‐Due, A., Pischke, S. E., Sandanger, Ø., Nilsson, P. H., Nunn, M. A., Denk, S., Gaus, W., Espevik, T., & Mollnes, T. E. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400341 · Cited by 61
The Role of the Classical Complement Cascade in Synapse Loss During Development and Glaucoma
Rosen, A. M., & Stevens, B. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-5635-4_6 · Cited by 60
Therapeutic targeting of the complement system in age‐related macular degeneration: a review
Troutbeck, R., Al‐Qureshi, S., & Guymer, R. H. (2012) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2011.02581.x · Cited by 60
Heinen, S., Józsi, M., Hartmann, A., Noris, M., Remuzzi, G., Skerka, C., & Zipfel, P. F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091069 · Cited by 59
Structure-based inhibition of protein–protein interactions
Watkins, A. M., & Arora, P. S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.047 · Cited by 56
Chimenti, M. S., Perricone, C., Graceffa, D., Muzio, G. D., Ballanti, E., Guarino, M. D., Conigliaro, P., Greco, E., Kroegler, B., & Perricone, R. (2012) · PubMed · Cited by 55
Hill, A., Ridley, S. H., Esser, D., Oldroyd, R. G., Cullen, M. J., Kareclas, P., Gallagher, S., Smith, G. P., Richards, S. J., White, J., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0782 · Cited by 53
DeAngelis, R. A., Reis, E. S., Ricklin, D., & Lambris, J. D. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.012 · Cited by 52
Diana, V., Pieramici, D. J., Campagne, M. V. L., Beres, T., Friesenhahn, M. J., Zhang, Y., & Strauss, E. C. (2013) · Retina · doi:10.1097/iae.0b013e3182979ddd · Cited by 51
Ali, Y. M., Hayat, A., Saeed, B. M., Haleem, K. S., Alshamrani, S., Kenawy, H. I., Ferreira, V. P., Saggu, G., Buchberger, A. M. S., Lachmann, P. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401011111 · Cited by 50
Woodruff, T. M., Strachan, A. J., Sanderson, S. D., Monk, P. N., Wong, A. K., Fairlie, D. P., & Taylor, S. M. (2001) · Inflammation · doi:10.1023/a:1011036414353 · Cited by 49
Khandhadia, S., Hakobyan, S., Heng, L. Z., Gibson, J., Adams, D. H., Alexander, G. J., Gibson, J. M., Martin, K. R., Menon, G., Nash, K., et al. (2013) · Ophthalmology · doi:10.1016/j.ophtha.2013.01.004 · Cited by 47
Self-citationSharp, J. A., Whitley, P. H., Cunnion, K. M., & Krishna, N. K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00406 · Cited by 46
C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice
Blom, A. M., Nandakumar, K. S., & Holmdahl, R. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.085753 · Cited by 46
Loyet, K. M., Good, J., Davancaze, T., Sturgeon, L., Wang, X., Yang, J., Le, K. N., Wong, M., Hass, P. E., Campagne, M. V. L., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.215921 · Cited by 46
Advances in the management of macular degeneration
Singer, M. A. (2014) · F1000Prime Reports · doi:10.12703/p6-29 · Cited by 43
Complement components as potential therapeutic targets for asthma treatment
Khan, M. A., Nicolls, M. R., Surguladze, B., & Saadoun, I. M. K. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.01.005 · Cited by 41
Banz, Y., Hess, O. M., ROBSON, S., Csizmadia, E., Mettler, D., Meier, P., Haeberli, A., SHAW, S., SMITH, R., & Rieben, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.07.016 · Cited by 40
Brief Report: Carboxypeptidase B Serves as a Protective Mediator in Osteoarthritis
Lepus, C. M., Song, J. J., Wang, Q., Wagner, C. A., Lindström, T. M., Chu, C. R., Sokolove, J. B., Leung, L. L. K., & Robinson, W. H. (2013) · Arthritis & Rheumatology · doi:10.1002/art.38213 · Cited by 39
Cavaliert, B., Mosca, M., Ramadori, P., Perrelli, M. G., Simone, L., Colotta, F., Bertini, R., Poli, G., & Cutrìn, J. C. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800307 · Cited by 37
Complement Involvement in Neovascular Ocular Diseases
Yanai, R., Thanos, A., & Connor, K. M. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0106-3_10 · Cited by 36
Elvington, M. L., Schepp-Berglind, J., & Tomlinson, S. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12464 · Cited by 36
Association of C2 and CFB Polymorphisms with Anterior Uveitis
Yang, M., Lai, T. Y. Y., Tam, P. O. S., Chiang, S. W. Y., Ng, T. K., Liu, K., & Pang, C. P. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-9478 · Cited by 33
Innate Immunity and the Etiology of Late-Onset Alzheimer’s Disease
Eikelenboom, P., van Exel, E. R., Veerhuis, R., Rozemüller, A. J. M., van Gool, W. A., & Hoozemans, J. J. M. (2012) · Neurodegenerative Diseases · doi:10.1159/000334287 · Cited by 32
Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation
Kim, S. J., Kim, J., Lee, J.-Y., Cho, S. Y., Kang, H. J., Kim, K.-Y., & Jin, D. (2012) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2012-302307 · Cited by 31
Therapeutic Inhibition of the Early Phase of Complement Activation
Roos, A., Ramwadhdoebé, T. H., Nauta, A. J., Hack, C. E., & Daha, M. R. (2002) · Immunobiology · doi:10.1078/0171-2985-00157 · Cited by 30
The effect of C1 inhibitor on intestinal ischemia and reperfusion injury
Lu, F., Chauhan, A. K., Fernandes, S. M., Walsh, M. T., Wagner, D. D., & Davis, A. E. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90460.2008 · Cited by 30
Vogel, C., Finnegan, P. W., & Fritzinger, D. C. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.035 · Cited by 28
Mauriello, C. T., Pallera, H. K., Sharp, J. A., Woltmann, J. L., Qian, S., Hair, P. S., van der Pol, P., van Kooten, C., Thielens, N. M., Lattanzio, F. A., et al. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.07.012 · Cited by 26
Distinct Roles of the Anaphylatoxins C3a and C5a in Dendritic Cell–Mediated Allergic Asthma
Engelke, C., Wiese, A. V., Schmudde, I., Ender, F., Ströver, H. A., Vollbrandt, T., König, P., Laumonnier, Y., & Köhl, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400080 · Cited by 25
Complement and the antiphospholipid syndrome
Lim, W. (2011) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283497f3e · Cited by 25
Structure of 3,4-Dichloroisocoumarin-Inhibited Factor D
Cole, L. B., Kilpatrick, J. M., Chu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444997010457 · Cited by 25
An evidence based therapeutic approach to hereditary and acquired angioedema
Bork, K. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000082 · Cited by 23
Inhibition of the Serine Proteases of the Complement System
Gál, P., Dobó, J., Beinrohr, L., Pál, G., & Závodszky, P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_2 · Cited by 23
Complotype affects the extent of down-regulation by Factor I of the C3b feedback cyclein vitro
Lay, E. M., Nutland, S. L., Smith, J. E., et al. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12437 · Cited by 22
Role of complement in a murine model of peanut-induced anaphylaxis
Kodama, T., Sekine, H., Takahashi, M., Iwaki, D., Machida, T., Kanno, K., Ishida, Y., Endo, Y., & Fujita, T. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.10.003 · Cited by 22
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE
Hu, X., Holers, V. M., Thurman, J. M., Schoeb, T. R., Ramos, T. N., & Barnum, S. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2012.12.018 · Cited by 18
Structure−Activity Relationships for Substrate-Based Inhibitors of Human Complement Factor B
Ruiz‐Gómez, G., Lim, J., Halili, M. A., Le, G. T., Madala, P. K., Abbenante, G., & Fairlie, D. P. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900781m · Cited by 16
Lee, M., Narayanan, S., McGeer, E. G., & McGeer, P. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087316 · Cited by 15
Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency
Zanichelli, A., Mansi, M., Periti, G., & Cicardi, M. (2013) · Expert Review of Clinical Immunology · doi:10.1586/eci.13.22 · Cited by 12
Noninvasive Detection of Complement Activation Through Radiologic Imaging
Thurman, J. M., & Rohrer, B. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_19 · Cited by 10
Antibody-mediates inhibition of human C1s and the classical complement pathway
Carroll, S., & Georgiou, G. (2013) · Immunobiology · doi:10.1016/j.imbio.2013.01.001 · Cited by 4
Potential Therapeutic for Idiopathic Inflammatory Myopathies
Bleecker, J. D., Creus, K. K., & Paepe, B. D. (2006) · Drug News & Perspectives · doi:10.1358/dnp.2006.19.9.1050424 · Cited by 4
Shigeyama (2000) · doi:10.1002/1529-0131(200011)43:11
Cited by
Berer, K., Gerdes, L. A., Cekanaviciute, E., Jia, X., Xiao, L., Xia, Z., Liu, C., Klotz, L., Stauffer, U., Baranzini, S. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711233114 · Cited by 933
Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense
Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P., & Lambris, J. D. (2016) · Immunological Reviews · doi:10.1111/imr.12500 · Cited by 484
New insights into the immune functions of complement
Reis, E. S., Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2019) · Nature Reviews Immunology · doi:10.1038/s41577-019-0168-x · Cited by 470
Pegcetacoplan versus eculizumab in paroxysmal nocturnal hemoglobinuria
Hillmen, P., Szer, J., Weitz, I., Röth, A., Höchsmann, B., Panse, J., Usuki, K., Griffin, M., Kiladjian, J.-J., de Castro, C., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2029073 · Cited by 440
Complement in cancer: untangling an intricate relationship
Reis, E. S., Mastellos, D. C., Ricklin, D., Mantovani, A., & Lambris, J. D. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.97 · Cited by 425
Metadata
- Authors
- Morgan, B. P., & Harris, C. L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2015-10-23
- Volume
- 14
- Issue
- 12
- Pages
- 857-877
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2298789261
- Cited by
- 431
- References
- 170
- FWCI
- 2.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.